Innate Pharma;Universita di Genova;Novo Nordisk A/S
发明人:
申请号：
EP06807262.8
公开号：
EP1934260B1
申请日:
2006.10.13
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention relates to methods of treating proliferative disorders, particularly immunoproliferative and autoimmune disorders, and methods of producing antibodies which bind NK cell receptors for use in therapeutic strategies for treating such disorders, particularly to deplete cells involved in the immunoproliferative pathology.
